Article
BRAF mutation in thyroid cancer.
Endocrine-related cancer - 1 Jun 2005
Xing M
Abstract excerpt
Genetic alteration is the driving force for thyroid tumorigenesis and progression, based upon which novel approaches to the management of thyroid cancer can be developed. A recent important genetic finding in thyroid cancer is the oncogenic T1799A transversion mutation of BRAF (the gene for the B-type Raf kinase, BRAF). Since the initial report of this mutation in thyroid cancer 2 years ago, rapid advancements...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
